BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 26371236)

  • 1. Drug Therapy for Heart Valve Diseases.
    Borer JS; Sharma A
    Circulation; 2015 Sep; 132(11):1038-45. PubMed ID: 26371236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do All Patients Need β-Blockers After a Heart Attack?
    Abbasi J
    JAMA; 2018 Mar; 319(9):853-855. PubMed ID: 29450492
    [No Abstract]   [Full Text] [Related]  

  • 3. Adding ACE inhibitors or ARBs to standard therapy for stable ischemic heart disease.
    Guirguis-Blake J
    Am Fam Physician; 2012 Jul; 86(1):21-3. PubMed ID: 22962909
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of atrial fibrillation.
    Kahali D; Mondal S
    J Indian Med Assoc; 2012 May; 110(5):297-301. PubMed ID: 23360021
    [No Abstract]   [Full Text] [Related]  

  • 5. An evidence-based review of recent advances in therapy for heart failure with reduced ejection fraction (HFrEF).
    Raj L; Adhyaru B
    Postgrad Med J; 2016 Dec; 92(1094):726-734. PubMed ID: 27708003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The predictors of resistance to standard drug therapy in patients with hypertension and heart valve calcification].
    Iuzvyshyna OV
    Lik Sprava; 2013 Jun; (4):18-24. PubMed ID: 25095679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Controversies in the Medical Management of Valvular Heart Disease.
    Barry AR; Wang EHZ
    Ann Pharmacother; 2021 Nov; 55(11):1379-1385. PubMed ID: 33550851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modern antihypertensive therapy: a report from the 22nd annual meeting of the American Society of Hypertension.
    Rabasseda X
    Timely Top Med Cardiovasc Dis; 2007 Jul; 11():E17. PubMed ID: 18297145
    [No Abstract]   [Full Text] [Related]  

  • 9. Difficulty accessing data from randomised trials of drugs for heart failure: a call for action.
    Fleetcroft R; Ford J; Gollop ND; MacKeith P; Perera K; Shafi AA; Sorefan J; Thurlow C; Wakelin R; Cowie MR; Steel N
    BMJ; 2015 Oct; 351():h5002. PubMed ID: 26489852
    [No Abstract]   [Full Text] [Related]  

  • 10. Secondary prevention following myocardial infarction: a clinical update.
    Isted A; Williams R; Oakeshott P
    Br J Gen Pract; 2018 Mar; 68(668):151-152. PubMed ID: 29472228
    [No Abstract]   [Full Text] [Related]  

  • 11. Implantable cardioverter-defibrillators.
    Aronow WS
    Am J Ther; 2010; 17(6):e208-20. PubMed ID: 19918166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data.
    Figtree GA; Vernon ST; Hadziosmanovic N; Sundström J; Alfredsson J; Arnott C; Delatour V; Leósdóttir M; Hagström E
    Lancet; 2021 Mar; 397(10279):1085-1094. PubMed ID: 33711294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can preventive therapy alter the initial presentation of coronary heart disease?
    Smith SC
    Ann Intern Med; 2006 Feb; 144(4):296-7. PubMed ID: 16490916
    [No Abstract]   [Full Text] [Related]  

  • 14. Polypill: for Pollyanna.
    Spence JD
    Int J Stroke; 2008 May; 3(2):92-7. PubMed ID: 18706002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Programs for continuing medical education: B session; 1. The pathophysiology of heart failure--is it the disease of the heart?].
    Kitakaze M
    Nihon Naika Gakkai Zasshi; 2014 Mar; 103(3):681-6. PubMed ID: 24796136
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of systolic heart failure in the elderly: an evidence-based review.
    Arif SA; Mergenhagen KA; Del Carpio RO; Ho C
    Ann Pharmacother; 2010 Oct; 44(10):1604-14. PubMed ID: 20841514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of other drugs apart from antithrombotic and antiplatelet agents for the treatment of non-ST-elevation acute coronary syndromes].
    Birdane A; Ata N
    Anadolu Kardiyol Derg; 2006 Apr; 6 Suppl 1():30-4. PubMed ID: 16613773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical management after myocardial infarction.
    Aronow WS
    Future Cardiol; 2019 May; 15(3):135-138. PubMed ID: 31148480
    [No Abstract]   [Full Text] [Related]  

  • 19. The pharmacological management of heart failure: too many treatments?
    van Veldhuisen DJ; van Gilst WH
    Eur J Heart Fail; 2003 Jan; 5(1):5-8. PubMed ID: 12559208
    [No Abstract]   [Full Text] [Related]  

  • 20. [It is necessary to modify or to optimize the preoperative treatment?].
    Piriou V
    Ann Fr Anesth Reanim; 2007 Dec; 26(12):1104-7. PubMed ID: 17997076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.